|
|
Board of Directors
The WBBA’s Board of Directors is comprised of knowledgeable and experienced professionals from the life sciences sector in Washington state. The Board of Directors actively oversees our policies and strategy. Composed of members of the Board, the Executive Committee is charged with monthly review of our financial performance and WBBA strategic directions. Please contact WBBA President Chris Rivera (chris@washbio.org) or Executive Committee Chair Tom Clement (clement@pathwaymedical.com).
2010 Executive Committee
- Chair – Thomas Clement, Pathway Medical Technologies, Inc.
- Treasurer – Margaret McCormick, PhD, Targeted Growth
- Secretary – Kevin Kelly, Cooley, Godward Kronish LLP
- President – Chris E. Rivera, WBBA
- Member – Thong Le, WRF Capital
- Member - Jack Nagan, Benaroya Research Institute at Virginia Mason, and Virginia Mason Medical Center
- Member – Erik Nilsson, Insilicos
- Member – Gregory Sessler, Spiration, Inc.
- Member - Martin Simonetti, VLST Corporation
- Member - Todd Simpson, Seattle Genetics, Inc.
- Member - Terry Sweeney, Philips Ultrasound
Board Members
- Norman Beauchamp, M.D., Professor, University of Washington School of Medicine
- D. William Brady, Jr., Senior Manager, KPMG LLP
- Michelle Burris, Sr. VP & COO, Trubion Pharmaceuticals, Inc.
- Cathryn Campbell J.D., Ph.D., General Counsel, Institute of Systems Biology
- Lisa Cohen, Executive Director, Washington Global Health Alliance
- Rob Derry, Investment Advisor Northwest, SVB Asset Management
- Ed Drosdick, Co-Chair, Technology & Life Sciences Group, Moss Adams LLP
- Christopher J. Elias, MD, MPH, President, PATH – Program for Appropriate Technology in Health
- H. Perry Fell, PhD, President and CEO, NanoString Technologies
- Don Foster, Vice President, Inflammation, Novo Nordisk
- Alan D. Frazier, Founder and Managing Partner, Frazier Healthcare Ventures
- Tom Fritz, CEO, Inland Northwest Health Services
- Carol Gallagher, CEO, Calistoga Pharmaceuticals, Inc.
- John Gardner, PhD, VP for Economic Development and Global Engagement, Washington State University
- Brett V. Gaspers, Managing Director, Objective Insights
- Mitchell H. Gold, MD, CEO, Dendreon Corporation
- James Gore, Vice President, Pacific Northwest Diabetes Research Institute
- Stephen M. Graham, Partner, Fenwick & West LLP
- Douglas R. Hansmann, PhD, COO and Co-Founder, EKOS Corporation
- John F. Harris, President & CEO, NeuroVista Corporation
- James B. Hendricks, PhD, President, Seattle Children’s Research Institute
- Lee Huntsman, PhD, Executive Director, Life Sciences Discovery Fund
- Mike Hutchings, Partner, DLA Piper US LLP
- Bruce Jackson, Business Development, enterpriseSeattle
- Terry Johnson, VP & Director, Battelle Centers for Public Health Research & Evaluation
- Allan Jones, PhD, Chief Scientific Officer, Allen Institute for Brain Science
- Jim Karkanias, Senior Director of Applied Research and Technology, Health Solutions Group, Microsoft
- Deborah Knutson, President, EDC of Snohomish County
- Gary Kocher, Partner, K&L Gates LLP
- Sally Lin, MBA Biotech Club, University of Washington
- Jim Lisbakken, Partner and Chair of Life Sciences Practice Group, Perkins Coie LLP
- Gustavo Mahler, PhD, President, CMC ICOS Biologics
- Tim Martin, Director of State Government Relations, Amgen
- Katherine McKenzie, President Emeritus, SEBA
- Eric Meier, President and CEO, Calypso Medical Technologies
- Ulrich Mueller, Vice President, Industry Relations and Technology Licensing, Fred Hutchinson Cancer Research Center
- Jens Quistgaard, President and CEO, Medicis Technologies
- Erick Rabins, Chief Business Officer, C3 Jian, Inc.
- Lisa Shaffer, PhD, Signature Genomic Laboratories
- Ken Stuart, PhD, Director and President, Seattle Biomedical Research Institute
- Ronald Thomas, Commercialization Manager, Battelle Pacific Northwest Division - PNNL
- Carl Weissman, President and CEO, Accelerator Corporation
- Joseph P. Whitford, Partner, Davis Wright Tremaine
|
